355 related articles for article (PubMed ID: 25652254)
1. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Kim SH; Lee JM; Gupta SN; Han JK; Choi BI
J Magn Reson Imaging; 2014 Sep; 40(3):730-7. PubMed ID: 24307571
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
4. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
Zou HH; Yu J; Wei Y; Wu JF; Xu Q
J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation.
Intven M; Reerink O; Philippens ME
J Magn Reson Imaging; 2015 Jun; 41(6):1646-53. PubMed ID: 25124320
[TBL] [Abstract][Full Text] [Related]
7. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience.
De Cecco CN; Ciolina M; Caruso D; Rengo M; Ganeshan B; Meinel FG; Musio D; De Felice F; Tombolini V; Laghi A
Abdom Radiol (NY); 2016 Sep; 41(9):1728-35. PubMed ID: 27056748
[TBL] [Abstract][Full Text] [Related]
8. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in restaging rectal cancer after neoadjuvant chemoradiotherapy.
Zhan S; Wang X; Huang X; Zhu H
J BUON; 2015; 20(1):62-7. PubMed ID: 25778298
[TBL] [Abstract][Full Text] [Related]
10. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
11. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Gollub MJ; Gultekin DH; Akin O; Do RK; Fuqua JL; Gonen M; Kuk D; Weiser M; Saltz L; Schrag D; Goodman K; Paty P; Guillem J; Nash GM; Temple L; Shia J; Schwartz LH
Eur Radiol; 2012 Apr; 22(4):821-31. PubMed ID: 22101743
[TBL] [Abstract][Full Text] [Related]
13. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
15. Can perfusion MRI predict response to preoperative treatment in rectal cancer?
Martens MH; Subhani S; Heijnen LA; Lambregts DM; Buijsen J; Maas M; Riedl RG; Jeukens CR; Beets GL; Kluza E; Beets-Tan RG
Radiother Oncol; 2015 Feb; 114(2):218-23. PubMed ID: 25497874
[TBL] [Abstract][Full Text] [Related]
16. [The value of MR T2WI signal intensity related parameters for predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer].
Wan LJ; Zhang CD; Zhang HM; Meng YK; Ye F; Liu Y; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):837-843. PubMed ID: 31770851
[No Abstract] [Full Text] [Related]
17. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
[TBL] [Abstract][Full Text] [Related]
18. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
Intven M; Monninkhof EM; Reerink O; Philippens ME
Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
[TBL] [Abstract][Full Text] [Related]
19. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
